Call Options Transactions Made in Q3 2024 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q3 2024. The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
CALL |
124KNew |
$317K - $317K
|
124K
$317K
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
CALL |
100KNew |
$257K - $257K
|
100K
$257K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
62.9KNew |
$162K - $162K
|
62.9K
$162K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
53K+ 68.92% |
$136K - $136K
|
130K
$334K
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
49K+ 99.8% |
$126K - $126K
|
98.1K
$252K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
13.2K+ 22.41% |
$33.9K - $33.9K
|
72.1K
$185K
|
|
|
Nov 14, 2024
Q3 2024
|
Graham Capital Management, L.P.
Rowayton, CT |
BUY
|
CALL |
8KNew |
$20.6K - $20.6K
|
8K
$20.6K
|
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
1.8K+ 6.82% |
$4.63K - $4.63K
|
28.2K
$72.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Css LLC
Chicago, IL |
BUY
|
CALL |
800New |
$2.06K - $2.06K
|
800
$2.06K
|
|
|
Oct 18, 2024
Q3 2024
|
Equitec Proprietary Markets, LLC
|
BUY
|
CALL |
300New |
$771 - $771
|
300
$771
|
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-33.1K- 67.14% |
$85.1K - $85.1K
|
16.2K
$41.6K
|